Ontology highlight
ABSTRACT:
INSTRUMENT(S): LTQ Orbitrap XL
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Tongue, Tonsil, Palate
DISEASE(S): Head And Neck Squamous Cell Carcinoma
SUBMITTER: Lena Mühlenbruch
LAB HEAD: Simon Laban
PROVIDER: PXD033383 | Pride | 2023-02-27
REPOSITORIES: Pride
Action | DRS | |||
---|---|---|---|---|
OPSCC_01_ClassII_Rep-1.msf | Msf | |||
OPSCC_01_ClassII_Rep-1.raw | Raw | |||
OPSCC_01_ClassII_Rep-2.msf | Msf | |||
OPSCC_01_ClassII_Rep-2.raw | Raw | |||
OPSCC_01_ClassII_Rep-3.msf | Msf |
Items per page: 5 1 - 5 of 564 |
Mühlenbruch Lena L Abou-Kors Tsima T Dubbelaar Marissa L ML Bichmann Leon L Kohlbacher Oliver O Bens Martin M Thomas Jaya J Ezić Jasmin J Kraus Johann M JM Kestler Hans A HA von Witzleben Adrian A Mytilineos Joannis J Fürst Daniel D Engelhardt Daphne D Doescher Johannes J Greve Jens J Schuler Patrick J PJ Theodoraki Marie-Nicole MN Brunner Cornelia C Hoffmann Thomas K TK Rammensee Hans-Georg HG Walz Juliane S JS Laban Simon S
British journal of cancer 20230223 9
<h4>Background</h4>The immune peptidome of OPSCC has not previously been studied. Cancer-antigen specific vaccination may improve clinical outcome and efficacy of immune checkpoint inhibitors such as PD1/PD-L1 antibodies.<h4>Methods</h4>Mapping of the OPSCC HLA ligandome was performed by mass spectrometry (MS) based analysis of naturally presented HLA ligands isolated from tumour tissue samples (n = 40) using immunoaffinity purification. The cohort included 22 HPV-positive (primarily HPV-16) and ...[more]